Paloma Partners’s Precigen PGEN Stock Holding History

Paloma Partners’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-20,529	Closed	-$72K	–	2095
2020 Q3	$72K	Buy	+20,529	New	+$97.4K	﹤0.01%	1945
2019 Q4	–	Sell	-27,409	Closed	-$157K	–	2419
2019 Q3	$157K	Buy	+27,409	New	+$186K	﹤0.01%	1789
2019 Q2	–	Sell	-50,994	Closed	-$268K	–	2086
2019 Q1	$268K	Buy	+50,994	New	+$354K	0.01%	1362
2017 Q3	–	Sell	-16,181	Closed	-$390K	–	2352
2017 Q2	$390K	Buy	+16,181	New	+$355K	﹤0.01%	1680
2016 Q2	–	Sell	-48,178	Closed	-$1.62M	–	2291
2016 Q1	$1.62M	Buy	+48,178	New	+$1.52M	0.03%	585
2015 Q3	–	Sell	-131,624	Closed	-$6.37M	–	1838
2015 Q2	$6.37M	Buy	+131,624	New	+$5.55M	0.12%	165
2014 Q4	–	Sell	-10,463	Closed	-$186K	–	1316
2014 Q3	$186K	Buy	+10,463	New	+$214K	0.01%	853

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paloma Partners's PGEN Position: Q4 2020 in Review

Paloma Partners sold out of Precigen (PGEN) in Q4 2020, closing a stake of 20,529 shares — an estimated $72K sold.

Paloma Partners first reported a position in PGEN in Q3 2014 and held it in 7 quarters. The position peaked at $6.37M in Q2 2015. 151 funds tracked by Wall St. Rank hold PGEN as of Q4 2020.

Paloma Partners reported no remaining Precigen position as of Q4 2020 after selling out during the quarter.
Paloma Partners sold 20,529 Precigen shares in Q4 2020, an estimated $72K.
Paloma Partners first reported a position in Precigen in Q3 2014 and held it in 7 quarters.
Paloma Partners's Precigen position peaked at $6.37M in Q2 2015.
151 funds tracked by Wall St. Rank held Precigen as of Q4 2020.

Based on Paloma Partners's 13F filing for Q4 2020, filed 16 Feb 2021.